Our disclosure log publishes responses that we have provided under the Freedom of Information Act (FOIA). They are displayed by subject and in the order in which they were received. If you would like to make a request under the FOIA please check here first to see if the information you need has already been released.
If you have any comments or queries about the log please contact uclh.
| Title | Description | FOI Category | Date Received |
|---|---|---|---|
| Ref no FOI.2024.0612 Response | |||
| Ref no FOI.2019.209 239 and 252 254 and 263 286 Response | |||
| Ref no-FOI.2018.654 Response Info Supplied | |||
| Ref no FOI.2019.547 Response | |||
| Ref no FOI.2024.0465 Response | |||
| Ref no FOI.2024.0465 Response | |||
| Ref no FOI.2020.0177 Response | FOI/2020/0177 - Bereavement services | Bereavement services | 05/03/2020 |
| FOI2017257Response | FOI2017257 Public health funerals | Bereavement services | 07/04/2017 |
| Ref no FOI.2020.0106 Response | FOI/2020/0106 - Bereavement service | Bereavement services | 04/02/2020 |
| Ref no FOI.2023.0810 Response | FOI/2023/0810 - Inflammatory Bowel Disease colorectal cancer colonoscopy surveillance endoscopy | Cancer | 27/10/2023 |
| Ref no FOI.2024.0582 Response | FOI/2024/0582 - SACT (systemic anti-cancer therapy) treatments for endometrial cancer | Cancer | 08/07/2024 |
| Ref no FOI.2023.0879 Response | FOI/2023/0879 - Incidence and treatment of colorectal cancer | Cancer | 20/11/2023 |
| Ref no FOI.2023.0875 Response | FOI/2023/0875 - Treatment for bladder cancer | Cancer | 17/11/2023 |
| Ref no FOI.2023.0831 Response | FOI/2023/0831 - Treatments for acute myeloid leukaemia/ chronic lymphocytic leukaemia | Cancer | 06/11/2023 |
| Ref no FOI.2022.0637 Response | FOI/2022/0637 - Breast cancer treatment | Cancer | 18/10/2022 |
| Ref no FOI.2022.0097 Response | FOI/2022/0097 - Incidence and treatment of breast cancer | Cancer | 18/02/2022 |
| Ref no FOI.2021.0220 Response | FOI/2021/0220 - Cancer referrals | Cancer | 21/04/2021 |
| Ref no FOI.2023.0808 Response | FOI/2023/0808 - Full blood count tests for chemotherapy cancer treatment | Cancer | 26/10/2023 |
| Ref no FOI.2024.0626 Response | FOI/2024/0626 - Number of patients with Waldenström Macroglobulinemia and treatments | Cancer | 24/07/2024 |
| Ref no FOI.2022.0456 Response | FOI/2022/0456 - Treatment of renal cell carcinoma | Cancer | 01/08/2022 |
| Ref no FOI.2023.0750 Response | FOI/2023/0750 - Treatment for non-small cell lung cancer | Cancer | |
| Ref No FOI.2021.0602 Response | FOI/2021/0602 - Chemotherapy units staffing treating adults with cancer | Cancer | 19/10/2021 |
| Ref no FOI.2023.0422 Response | FOI/2023/0422 - Renal cell treatment for carcinoma and melanoma | Cancer | 16/06/2023 |
| Ref no FOI.2023.0811 Response | FOI/2023/0811 - HIFU partial ablation/ prostate cancer detection | Cancer | 30/10/2023 |
| Ref no FOI.2020.0368 Response | FOI/2020/0368 - Proton beam therapy centre | Cancer | 22/07/2020 |
| Ref no FOI.2020.0409 Response | FOI/2020/0409 - Number of cancelled cancer operations since March 2020 | Cancer | 10/08/2020 |
| Ref no FOI.2024.0577 Response | FOI/2024/0577 - Diffuse Large B Cell Lymphoma treatments | Cancer | 08/07/2024 |
| Ref no FOI.2022.0091 Response | FOI/2022/0091 - Pancreatic cancer | Cancer | 16/02/2022 |
| Ref no FOI.2024.0603 Response | FOI/2024/0603 - Mouth cancer/ oral cancer referrals | Cancer | 17/07/2024 |
| Ref no FOI.2020.0267 Response | FOI/2020/0267 - Patients treated for head and neck cancer | Cancer | 19/05/2020 |
| Ref no FOI.2024.0070 Response | FOI/2024/0070 - Treatments for metastatic/ adjuvant melanoma, colorectal and lung cancers | Cancer | 23/01/2024 |
| Ref no FOI.2021.0364 Response | FOI/2021/0364 - Proton Beam Therapy unit/ machine | Cancer | 17/06/2021 |
| Ref no FOI.2021.0614 Response | FOI/2021/0614 - Chemotherapy units staffing treating adults with cancer | Cancer | 22/10/2021 |
| Ref no FOI.2019.19 Response | FOI/2019/19 Skin cancer MDTs | Cancer | 09/01/2019 |
| Ref no FOI.2024.0059 Response | FOI/2024/0059 - Late effects of cancer service | Cancer | 22/01/2024 |
| Ref no FOI.2022.0266 Response | FOI/2022/0266 - Drug Patient Level Contract Monitoring (DrPLCM)/ SACT cancer report | Cancer | 05/05/2022 |
| Ref no FOI.2023.0141 Response | FOI/2023/0141 - Longest cancer waits | Cancer | 20/02/2023 |
| Ref no FOI.2021.0349 Response | FOI/2021/0349 - Cancer treatment | Cancer | 11/06/2021 |
| Ref no FOI.2024.0435 Response | FOI/2024/0435 - Myeloma service provision | Cancer | 13/05/2024 |
| Ref no FOI.2020.0253 Response | FOI/2020/0253 - Breast cancer reporting/digital pathology | Cancer | 06/05/2020 |
| Ref no FOI.2021.0278 Response | FOI/2021/0278 - Cancer referrals | Cancer | 10/05/2021 |
| Ref no FOI.2024.0440 Response | FOI/2024/0440 - Patient reported outcome measures (PROMs) in oncology | Cancer | 14/05/2024 |
| Ref no FOI.2021.0322 Response | FOI/2021/0322 - Incidence and treatment of breast cancer | Cancer | 01/06/2021 |
| Ref no FOI.2022.0757 Response | FOI/2022/0757 - Oncology services - staff/ patients | Cancer | 07/12/2022 |
| Ref no FOI.2020.0287 Response | FOI/2020/0287 - Cancer waiting list | Cancer | 29/05/2020 |
| Ref no FOI.2023.0416 Response | FOI/2023/0416 - Treatments for non-small cell lung cancer | Cancer | 15/06/2023 |
| Ref no FOI.2023.0954 Response | FOI/2023/0954 - Treatment of melanoma/ Renal cell carcinoma/ Oesophageal cancer | Cancer | 15/12/2023 |
| Ref no FOI.2024.0427 Response | FOI/2024/0427 - Oncology dispensing volume levels for Dostarlimab, Acalabrutinib, Olaparib, Osimertinib and Durvalumab | Cancer | 10/05/2024 |
| Ref no FOI.2023.0429 Response | FOI/2023/0429 - Breast cancer treatment/ systemic anti-cancer therapies | Cancer | 20/06/2023 |
| Ref no FOI.2023.0008 Response | FOI/2023/0008 - Oesophageal and gastric cancer | Cancer | 05/01/2023 |
